The Challenge of Change - Managing Excipients Control
Colorcon
05-May-2011 - Merck South Africa, a subsidiary of German pharma giant, Merck KGaA, has sold its Merck Pharmaceutical Manufacturing (MPM) operations in Johannesburg to investment firm, Nkunzi Investment Holdings.
05-May-2011 - Albany Molecular Research (AMRI) posted a modest net loss on costs and restructuring charges, but saw revenue grow considerably in the first quarter thanks to contracting business and royalties.
04-May-2011 - Non-profit epilepsy research sponsor, Epilepsy Therapy Project (ETP), has announced it is to invest in central nervous system (CNS) drug delivery specialist, ICVrx, to support the development of novel drug tech designed to tackle refractory epilepsy.
03-May-2011 - International Specialty Products (ISP) has announced plans to raise its prices by 10 per cent in response to increasing raw material and energy costs.
03-May-2011 - in-PharmaTechnologist presents a round up of biopharm manufacturing expansions, including details of new plants for OmniLytics and Morphotek.
02-May-2011 - Strides’ oncology plant in Bangalore, India has been approved by the FDA, positioning the company to enter the US market.
02-May-2011 - The second draft of Excipact, a set of certification standards for drug excipient producers being developed by the EFCG, FECC, IPEC and PQD, has been sent to industry stakeholders for consultation.
28-Apr-2011 - US drug developer, PharmStar Pharmaceuticals, has reached an agreement to buy a new 24,000 square foot manufacturing facility in Wilson, North Carolina.
27-Apr-2011 - The United States Pharmacopeial Convention (USP) and the Chinese Pharmacopoeia Commission (ChP) have made mutual executive appointments in an effort to further align drug quality standards.
27-Apr-2011 - Pharma giant Eli Lilly and medical device maker Medtronic are to collaborate on the research and development of an implantable drug delivery system for the treatment of Parkinson’s disease.
26-Apr-2011 - Biogen Idec and Merck & Co are expanding capabilities and adding jobs in Durham, North Carolina, US.
21-Apr-2011 - Gilead has entered into a licence and collaboration agreement with drug delivery specialists MicroDose Therapeutx to develop a treatment for respiratory syncytial virus (RSV).
21-Apr-2011 - China-based Hebei Aoxing is to produce naloxone hydrochloride API after it successfully adopted new drug processing technology.
19-Apr-2011 - US-based tissue regeneration specialist, Organogensis, has broken ground on the construction of the world’s largest automated living cell manufacturing plant in Canton, Massachusetts.
19-Apr-2011 - The IFPMA has welcomed a WHO proposal to fund creation of extra vaccine production capacity to cope with global influenza epidemics.
18-Apr-2011 - MENA-focused drug manufacturer, Hikma, has entered into a strategic partnership with Indian API and intermediates business, Unimark Remedies.
14-Apr-2011 - Access Pharmaceuticals’ targeted RNAi delivery technology will be used by a pharma major after the companies inked a deal.
14-Apr-2011 - Univar has announced plans to ramp up capacity for medicinal white oils, predicting that increased regulatory focus on supply chain integrity will drive drug industry demand.
13-Apr-2011 - Dr Reddy’s Laboratories has moved its UK subsidiary, Chirotech, to a new purpose built lab facility at the Cambridge Science Park.
12-Apr-2011 - Delivery technology firm Monosol Rx has been grated a US patent for production of pharmaceutical films containing certain antiemetics, analgesics and antiabetics.
12-Apr-2011 - Nano Terra, a surface engineering and nanotechnology company based in Brighton Massachusetts, US, has struck a deal to acquire neighbouring drug developer, Surface Logix.
12-Apr-2011 - PanGen Biotech is to supply Compass Biotechnologies with APIs for biobetters after signing a memorandum of understanding (MOU).
11-Apr-2011 - Bend Research, the Oregon US-based drug manufacturer, has received a new US patent covering the use of polymer additives to help increase the efficacy of low-solubility drugs.
07-Apr-2011 - US delivery technology firm Fuisz Pharma has developed an oral dosage form with improved compliance characteristics.
05-Apr-2011 - Pharmaceutical giant Pfizer has agreed to sell Capsugel, its drug delivery technology unit, to US investment group Kohlberg Kravis Roberts & Co (KKR) for $2.4bn (€1.7bn).